MARKET

ACON

ACON

Aclarion Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9100
+0.0280
+3.17%
Opening 10:42 08/18 EDT
OPEN
0.9030
PREV CLOSE
0.8820
HIGH
0.9130
LOW
0.8830
VOLUME
14.80K
TURNOVER
6.78K
52 WEEK HIGH
4.050
52 WEEK LOW
0.7825
MARKET CAP
7.12M
P/E (TTM)
-1.1952
1D
5D
1M
3M
1Y
5Y
Aclarion, Inc. to Present at Investor Summit Group's Q3 Virtual Conference
Broomfield, Colorado--(Newsfile Corp. - August 4, 2022) - Aclarion, Inc. (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers and proprietary algorithms to identify the location of chro...
Newsfile · 08/04 11:00
Quite a few insiders invested in Aclarion, Inc. (NASDAQ:ACON) last year which is positive news for shareholders
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
Simply Wall St. · 07/22 13:01
Aclarion Announces Start of Healthcare Economic Analysis Study to Evaluate Financial Impact of Nociscan
Initial findings from the EVAL study are expected to be released in Q4 2022Study initiated to assess impact of Nociscan on the cost of care for chronic low back pain (CLBP) patientsPromising initial clinical evaluations with 87% of patients treated at disc...
ACCESSWIRE · 07/20 11:00
Aclarion Launches Study to Evaluate Financial Impact of Nociscan; Shares Up Pre-Bell
MT Newswires · 07/20 07:44
--Maxim Starts Aclarion at Buy With $3 Price Target
MT Newswires · 07/06 08:04
40 Stocks Moving In Wednesday's Mid-Day Session
 Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Benzinga · 06/22 16:17
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Benzinga · 06/22 12:06
Stocks That Hit 52-Week Lows On Monday
  Monday's session saw 84 companies set new 52-week lows.
Benzinga · 06/09 17:21
More
No Data
Learn about the latest financial forecast of ACON. Analyze the recent business situations of Aclarion Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ACON stock price target is 3.000 with a high estimate of 3.000 and a low estimate of 3.000.
High3.000
Average3.000
Low3.000
Current 0.9100
EPS
Actual
Estimate
-0.39-0.29-0.20-0.10
Q1 2022
Q2 2022
Q3 2022
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-1.57%
Pharmaceuticals & Medical Research
-0.70%
Key Executives
Chairman/Executive Director
Jeff Thramann
President/Chief Executive Officer/Director
Brent Ness
Chief Financial Officer
John Lorbiecki
Other
Ryan Bond
Director
David Neal
Independent Director
Scott Breidbart
Independent Director
Steve Deitsch
Independent Director
Amanda Sequira
Independent Director
William Wesemann
No Data
No Data
About ACON
Aclarion, Inc. is a healthcare technology company that employs magnetic resonance spectroscopy (MRS) and artificial intelligence (AI) technology to optimize clinical treatments. The Company’s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Its first commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. NOCISCAN is a software as a service (SaaS) platform to leverage MRS to non-invasively help physicians distinguish between painful and nonpainful discs in the spine. The platform used to conduct a NOCISCAN-LS involves NOCISCAN-LS MRS exam protocol, data transfer, and the NOCISCAN-LS post-processor suite. The Company’s NOCISCAN-LS post processor suite is comprised of two software products, such as NOCICALC-LS and NOCIGRAM.

Webull offers kinds of Aclarion Inc stock information, including NASDAQ:ACON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACON stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACON stock methods without spending real money on the virtual paper trading platform.